Exscientia
Exscientia Shifts Focus: Consolidates ‘Rapidly Emerging Pipeline’ to Emphasize 2 Key Oncology Programs
Anika Sharma
Exscientia, an AI-driven precision medicine company, is streamlining its pipeline to concentrate on the highest-value opportunities. The company is focusing ...
Merck KGaA signs two deals with BenevolentAI and Exscientia to boost AI-driven drug discovery in oncology and immunology
Anika Sharma
Merck KGaA is making strategic moves in the field of AI-enabled drug discovery by entering into three-target partnerships with BenevolentAI ...
